Ignyta Appoints William Mccarthy As Chief Business Officer
SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc. (Nasdaq: RXDX), a precision oncology biotechnology company, announced today that William McCarthy has been appointed to the newly-created role of Chief Business Officer.
“We are excited to expand our leadership capacity at Ignyta with the addition of Will to our executive team,” said Jonathan Lim, M.D., Chairman and CEO of Ignyta. “Will brings to Ignyta broad commercial and corporate development experience gained from senior roles in leading biotech and diagnostic companies, most recently responsible for corporate and business development activities at Foundation Medicine, another leading precision medicine company. Ignyta will benefit from his proven track record and expertise in new product planning, corporate development and alliance management as we seek to provide new treatment options for cancer patients.”
“We are excited to expand our leadership capacity at Ignyta with the addition of Will to our executive team,” said Jonathan Lim, M.D., Chairman and CEO of Ignyta. “Will brings to Ignyta broad commercial and corporate development experience gained from senior roles in leading biotech and diagnostic companies, most recently responsible for corporate and business development activities at Foundation Medicine, another leading precision medicine company. Ignyta will benefit from his proven track record and expertise in new product planning, corporate development and alliance management as we seek to provide new treatment options for cancer patients.”